379 related articles for article (PubMed ID: 11882576)
1. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
[TBL] [Abstract][Full Text] [Related]
2. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
[TBL] [Abstract][Full Text] [Related]
3. Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.
Yang XP; Liu YH; Shesely EG; Bulagannawar M; Liu F; Carretero OA
Hypertension; 1999 Jul; 34(1):24-30. PubMed ID: 10406819
[TBL] [Abstract][Full Text] [Related]
4. Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice.
Xu J; Carretero OA; Liu YH; Shesely EG; Yang F; Kapke A; Yang XP
Hypertension; 2002 Sep; 40(3):244-50. PubMed ID: 12215461
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
6. Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
Cavasin MA; Yang XP; Liu YH; Mehta D; Karumanchi R; Bulagannawar M; Carretero OA
J Cardiovasc Pharmacol; 2000 Oct; 36(4):472-80. PubMed ID: 11026648
[TBL] [Abstract][Full Text] [Related]
7. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
8. The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice.
Xu J; Carretero OA; Shesely EG; Rhaleb NE; Yang JJ; Bader M; Yang XP
Exp Physiol; 2009 Mar; 94(3):322-9. PubMed ID: 19060116
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
Scherrer-Crosbie M; Ullrich R; Bloch KD; Nakajima H; Nasseri B; Aretz HT; Lindsey ML; Vançon AC; Huang PL; Lee RT; Zapol WM; Picard MH
Circulation; 2001 Sep; 104(11):1286-91. PubMed ID: 11551881
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA
Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction.
Liu YH; Wang D; Rhaleb NE; Yang XP; Xu J; Sankey SS; Rudolph AE; Carretero OA
J Card Fail; 2005 Feb; 11(1):74-81. PubMed ID: 15704068
[TBL] [Abstract][Full Text] [Related]
12. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.
Liu YH; Carretero OA; Cingolani OH; Liao TD; Sun Y; Xu J; Li LY; Pagano PJ; Yang JJ; Yang XP
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2616-23. PubMed ID: 16055518
[TBL] [Abstract][Full Text] [Related]
13. Role of a selective aldosterone blocker in mice with chronic heart failure.
Wang D; Liu YH; Yang XP; Rhaleb NE; Xu J; Peterson E; Rudolph AE; Carretero OA
J Card Fail; 2004 Feb; 10(1):67-73. PubMed ID: 14966777
[TBL] [Abstract][Full Text] [Related]
14. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
[TBL] [Abstract][Full Text] [Related]
16. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats.
Liu YH; Yang XP; Mehta D; Bulagannawar M; Scicli GM; Carretero OA
Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H507-14. PubMed ID: 10666082
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction.
Kompa AR; Lu J; Weller TJ; Kelly DJ; Krum H; von Lueder TG; Wang BH
Int J Cardiol; 2018 May; 258():192-198. PubMed ID: 29544929
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
[TBL] [Abstract][Full Text] [Related]
19. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction.
Sam F; Sawyer DB; Xie Z; Chang DL; Ngoy S; Brenner DA; Siwik DA; Singh K; Apstein CS; Colucci WS
Circ Res; 2001 Aug; 89(4):351-6. PubMed ID: 11509452
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
